Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/Phase 2 vaccine therapy trial for metastatic melanoma. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: UNKNOWN